TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07408258: A Multicenter, Open-label Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

Sponsor: OncoC4, Inc. · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 20 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$502,656

Rescue Site Savings

+$345,576

Unlock Full NCT07408258 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07408258 Rescue Dossier →